System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Bertrand Cariou

Endocrinology — Centre Hospitalier Universitaire de Nantes, France

LeadR Profile

Bertrand Cariou Centre Hospitalier Universitaire de Nantes France
3 109 ScienceLeadR Reputation 3109

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Cardiology - Hepatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Nantes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 656

Citations

Citations: 39 999 1st author: 79 Last author: 98 Unique author: 29

Main journals

Diabetes Metab 85
Ann Endocrinol (Paris) 57
Atherosclerosis 41
Diabetes Obes Metab 26
Diabetes Care 21

Best Journals

N Engl J Med 10
Circulation 7
J Hepatol 7

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Impact of a 2-year structured program on physical fitness and physical activity in T2D patients with rapid renal function decline-the ACTIDIANE RCT.
exercise, physical fitness, diabetes mellitus, type 2		Front Sports Act Living20260
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.
glucagon-like peptide 1, quality of life, safety, cardiovascular diseases, frailty, semaglutide		JAMA Cardiol20260
Low Cholesterol and Liver Risk-The Mechanism Matters.
liver, clinical medicine, cholesterol		JAMA Netw Open20260
Tripartite ER-mitochondria-lipid droplets contact sites control adipocyte metabolic flexibility.
lipid droplets, molecular biology, mitochondria, adipocytes, calcium, obesity		EMBO J20263
Low-density lipoprotein cholesterol management and goal attainment at 1 year in patients with diabetes, pre-diabetes and normoglycaemia: results from the European, prospective, observational SANTORINI study.
diabetes mellitus, cholesterol, ldl, lipoproteins, cholesterol, therapeutics, lipoproteins, ldl		BMJ Open20260

Clinical Studies 68

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 12 Study Chair: 3

By phase:

Phase 3 33
N/A 26
Phase 2 5
Phase 4 3
Phase 2/Phase 3 1

By status:

Completed 46
Recruiting 8
Unknown 7
Terminated 3
Active not recruiting 2
Not yet recruiting 2

By type:

Interventional 56
Observational 12

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 5
multicentric5to9 8
multicentricup10 38

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An open label extension (OLE) trial to evaluate long term safety and tolerability of pelacarsen (TQJ230)
2024-519870-38-00 — safety, cardiovascular diseases		Phase 3Not yet recruiting2026
Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterolemia
2024-514594-21-00 — hyperlipoproteinemia type ii, cholesterol, ldl, safety, aged, cholesterol, child, hypercholesterolemia		Phase 3Recruiting2025
A randomized double blind placebo controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high risk primary prevention patients (VICTORION 1 PREVENT)
2022-502779-40-00 — cardiovascular diseases, primary prevention		Phase 3Active not recruiting2023
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High Bad Cholesterol from an Inherited Condition
2025-520520-17-00 — cholesterol, ldl, lipoproteins, cholesterol, lipoproteins, ldl		Phase 3Active not recruiting2025
Impact of Artificial Intelligence Algorithm driven Versus Standard Lifestyle Intervention in Non Alcoholic Fatty Liver Disease A Multicenter Randomized Open label Controlled Trial
NCT07497750 — liver diseases, diabetes mellitus, depression, exercise, quality of life, intelligence, life style, eating, fibrosis, pain, non-alcoholic fatty liver disease, cooking, health status, magnetic resonance imaging, liver, algorithms, biomarkers, diet, alcoholics, food, work, software, meals, artificial intelligence, history, tissues, sedentary behavior, fatty liver, random allocation, snacks, patient satisfaction, fatty liver, alcoholic, lifestyle and wellness apps, fibroscan, lipids, liver stiffness		N/ANot yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS